Advertisements

Health Services News

Headlines for Health Services (HLTHSERV)
Sector News | Topic News
View News From :   To:   Page:    of 1107    
Sat, Oct 21, 2017
6:40 PM Veracyte Announces New Data Highlighting Performance of the Afirma GSC Ensemble Machine Learning Algorithms in Challenging Thyroid Cancer Subtypes to Be Presented at ATA - Business Wire
2:00 PM Real-World Study Shows ZEPATIER\u00AE (Elbasvir and Grazoprevir) Resulted in High Rates of Sustained Virologic Response in Patients with Chronic Hepatitis C Infection Who Have Chronic Kidney Disease - Business Wire
10:00 AM Tennesseans, Help Fight the Opioid Epidemic: Participate in National Drug Take-Back Day Oct. 28 - Business Wire
8:51 AM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Health Insurance Innovations, Inc. of Class Action Lawsuit and Upcoming Deadline - HIIQ - ACCESSWIRE IA
Fri, Oct 20, 2017
11:26 PM DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Health Insurance Innovations, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESSWIRE IA
10:50 PM HEALTH INSURANCE INNOVATIONS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Health Insurance Innovations - (HIIQ) - Business Wire
7:31 PM FPT Communique - Health Ministers' Meeting (HMM) - Canada Newswire
7:16 PM Shingrix approved in the US for prevention of shingles in adults aged 50 and over - PR Newswire
7:02 PM Pediatric Ophthalmologist Dr. Kim Cooper Announces Strabismus Lecture at The EYES of a Child Symposium - GlobeNewswire
7:00 PM FDA Approves GSK's Shingles Vaccine with Agenus' QS-21 Stimulon\u00AE Adjuvant - PR Newswire
6:49 PM Antares Pharma Receives Complete Response Letter From the FDA for XYOSTED(TM) - GlobeNewswire
5:16 PM DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age - GlobeNewswire
5:15 PM DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age - Thomson Reuters ONE
4:30 PM IMPORTANT INTERCEPT PHARMACEUTICALS, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Intercept Pharmaceuticals, Inc. - GlobeNewswire
4:23 PM Janssen Receives Two U.S. FDA Approvals For SIMPONI ARIA\u00AE (golimumab) For The Treatment Of Adults With Active Psoriatic Arthritis Or Active Ankylosing Spondylitis - PR Newswire
4:12 PM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT - ACCESSWIRE IA
4:05 PM Connecture, Inc. Announces Intention to Voluntarily Delist from the Nasdaq Global Market and List on the OTCQX Market - GlobeNewswire
4:05 PM BoxBar Vascular Opens Doors with Hands-On, State-of-the-Art Care - Business Wire
4:00 PM Xencor to Present Final Results from Phase 2 Study of XmAb\u00AE5871 in IgG4-Related Disease at American College of Rheumatology (ACR) 2017 Annual Meeting - PR Newswire
4:00 PM Amgen Announces Webcast of 2017 Third Quarter Financial Results - PR Newswire
3:21 PM UPDATE - Van der Pop to launch branded cannabis with WeedMD in November 2017 - Marketwired
3:21 PM UPDATE - Van der Pop to launch branded cannabis with WeedMD in November 2017 - Marketwired
3:18 PM RTI Surgical\u00AE Introduces TETRAfuse\u00AE 3D Technology Becoming First to Offer 3D Printed Interbody Polymer Optimized to Participate in Fusion - Business Wire
2:31 PM Permanente Physician Leaders Convene to Advance the Quadruple Aim in Health Care Delivery - Business Wire
2:19 PM MIV-711 Phase IIa Osteoarthritis Study Data Selected as Late Breaking Abstract at the Annual Meeting of the American College for Rheumatology - PR Newswire